PCV2 CLINICAL EXPERIENCE IN DYSLIPIDEMIC PATIENTS TREATED EITHER WITH ROSUVASTATIN 10 MG/DAY OR EZETIMIBE/SIMVASTATIN 10/20 MG/DAY IN MEXICO CITY. A RETROSPECTIVE ANALYSIS

May 1, 2007, 00:00
10.1016/S1098-3015(10)68646-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)68646-9/fulltext
Title : PCV2 CLINICAL EXPERIENCE IN DYSLIPIDEMIC PATIENTS TREATED EITHER WITH ROSUVASTATIN 10 MG/DAY OR EZETIMIBE/SIMVASTATIN 10/20 MG/DAY IN MEXICO CITY. A RETROSPECTIVE ANALYSIS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68646-9&doi=10.1016/S1098-3015(10)68646-9
First page :
Section Title :
Open access? : No
Section Order : 416
Categories :
Tags :
Regions :
ViH Article Tags :